ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Hoofdauteur: | R.T. Saygitov |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
"Paediatrician" Publishers LLC
2008-08-01
|
Reeks: | Вопросы современной педиатрии |
Online toegang: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Gelijkaardige items
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
door: R.T. Saygitov
Gepubliceerd in: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
door: Cardile S, et al.
Gepubliceerd in: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
door: Yu. V. Yevsyutina
Gepubliceerd in: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
door: Gold Benjamin D, et al.
Gepubliceerd in: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
door: Roy C Orlando, et al.
Gepubliceerd in: (2010-09-01)